IP Library Granted Patent US 8,326,401
Granted Patent B2
US 8,326,401 · App. 11/985,997 · Granted Dec 4, 2012

MRI detectable obturator

Assignee: Senorx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,326,401
App. No.
11/985,997
Granted
Dec 4, 2012
Kind
B2
Abstract

An obturator with an elongated shaft, a proximal end, a substantially closed distal end and a MRI detectable distal shaft portion, which does not interfere with magnetic resonance imaging of tissue proximate thereto. Preferably, the distal shaft portion has an effective MRI detectable mass so as to provide a clear, T1-weighted image within an outline of the distal shaft portion upon magnetic resonance imaging.

Claims (25)

1. An obturator for marking an intracorporeal site comprising an elongated shaft, a proximal end, a distal end, and an MRI detectable distal shaft portion which does not interfere with magnetic resonance imaging of tissue proximate thereto, the distal shaft portion having an effective amount of MRI detectable agent so as to provide a clear, T1-weighted image within an outline of the distal shaft portion upon magnetic resonance imaging thereof,

the distal shaft portion having an inner lumen and the MRI detectable agent being contained in an MRI detectable gelled mass within the inner lumen, the MRI detectable gelled mass being formed of an aqueous solution of a MRI contrast agent mixed with a hydrogel, with the MRI contrast agent selected from the group consisting of Gadiolinium Sulfate, Ferric Chloride and Ferrous Gluconate, and the aqueous solution has a concentration of the MRI contrast agent of at least 0.00002 molar.

2. The obturator of claim 1 wherein the group further consists of Gadolinium, Manganese, and Iron.

3. The obturator of claim 1 wherein the group further consists of GdCl 3 , Gd 2 O 3 gadopentetate dimeglumine (Gd-DPTA), Gd-EDTA, gadoteridol, gadoterate meglumine, mangafodipir trisodium and gadodiamide.

4. The obturator of claim 1 wherein the distal end is closed.

5. The obturator of claim 4 wherein the closed distal end is a penetratable membrane.

6. The obturator of claim 4 wherein the closed distal end of the obturator is formed of one or more petals.

7. The obturator of claim 4 wherein the closed distal end of the obturator is a valve.

8. The obturator of claim 1 , comprising a marker delivery member disposed within the inner lumen.

9. The obturator of claim 8 wherein the marker delivery member has a delivery lumen with one or more markers within the delivery lumen and a plunger slidably disposed within the delivery lumen and which is located proximal to the one or more markers.

10. The obturator of claim 9 wherein the proximal end of the plunger is enlarged.

11. The obturator of claim 9 wherein the marker delivery member has a needle shaped distal tip.

12. The obturator of claim 9 wherein the marker delivery tubular member has a blunt distal tip.

13. The obturator of claim 9 wherein the marker delivery shaft has depth markings.

14. The obturator of claim 9 wherein the proximal end of the obturator has a hub and the proximal end of the marker delivery member has a hub which is configured to fit within the hub of the obturator when the marker delivery shaft is inserted into the elongated shaft of the obturator.

15. The obturator of claim 9 wherein the marker delivery lumen contains a fluid proximal of the at least one tissue marker to facilitate discharge of the markers.

16. An obturator for marking an intracorporeal site comprising an elongated shaft, a proximal end, a distal end, and an MRI detectable distal shaft portion which does not interfere with magnetic resonance imaging of tissue proximate thereto, the distal shaft portion having an effective amount of MRI detectable agent so as to provide a clear, T1-weighted image within an outline of the distal shaft portion upon magnetic resonance imaging thereof,

the distal shaft portion having an inner lumen and the MRI detectable agent being contained in an MRI detectable gelled mass within the inner lumen, the MRI detectable gelled mass being formed of an aqueous solution of a MRI contrast agent mixed with a hydrogel, with the MRI contrast agent selected from the group consisting of Gadiolinium Sulfate, Ferric Chloride and Ferrous Gluconate, and a molar concentration of the MRI contrast agent is at least 0.00005 molar.

17. The obturator of claim 16 wherein the proximal end of the obturator has a hub, wherein the hub of the obturator has gripping ridges.

18. The obturator of claim 17 , comprising a marker delivery member disposed within the inner lumen, the marker delivery member having a marker delivery tubular shaft with a hub, wherein the hub of the marker delivery tubular shaft has gripping ridges.

19. The obturator of claim 16 wherein the obturator shaft is formed of a non-magnetic material.

20. The obturator of claim 16 wherein the obturator shaft is formed of a polymeric material.

21. The obturator of claim 20 wherein the polymeric material is a polycarbonate.

22. The obturator of claim 16 wherein the obturator shaft is configured to be used within a cannula of a biopsy device.

23. The obturator of claim 22 wherein the cannula has depth markings.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: LUBOCK, PAUL; JONES, MICHAEL L.; BROADAWAY, ETHAN; LOUW, FRANK R.
To: SENORX, INC.
Reel/Frame 020863/0425 →
Continuity (5)
Continuation In Part 11978782 · Oct 30, 2007
Continuation In Part 11980302 · Oct 30, 2007
Provisional Application 60860887 · Nov 24, 2006
Provisional Application 60872020 · Nov 30, 2006
Related Publication 20080139928A1 · Jun 12, 2008